DAXOR CORP(NASDAQ:DXR) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to DXR. DXR was compared to 189 industry peers in the Health Care Equipment & Supplies industry. While DXR seems to be doing ok healthwise, there are quite some concerns on its profitability. DXR is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year DXR was profitable.

In the past year DXR had a positive cash flow from operations.

DXR had positive earnings in 4 of the past 5 years.

DXR had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 1.46%, DXR is in the better half of the industry, outperforming 74.07% of the companies in the same industry.

DXR has a better Return On Equity (1.50%) than 74.60% of its industry peers.

		Industry Rank	Sector Rank
ROA	1.46%
ROE	1.5%
ROIC	N/A

ROA(3y)6.45%

ROA(5y)5.61%

ROE(3y)6.73%

ROE(5y)6.34%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

DXR's Profit Margin of 447.75% is amongst the best of the industry. DXR outperforms 99.47% of its industry peers.

DXR's Profit Margin has declined in the last couple of years.

The Operating Margin and Gross Margin are not available for DXR so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	447.75%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-35.84%

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for DXR has been increased compared to 1 year ago.

The number of shares outstanding for DXR has been increased compared to 5 years ago.

Compared to 1 year ago, DXR has an improved debt to assets ratio.

2.2 Solvency

DXR has an Altman-Z score of 27.92. This indicates that DXR is financially healthy and has little risk of bankruptcy at the moment.

DXR has a better Altman-Z score (27.92) than 96.83% of its industry peers.

The Debt to FCF ratio of DXR is 28.40, which is on the high side as it means it would take DXR, 28.40 years of fcf income to pay off all of its debts.

With a decent Debt to FCF ratio value of 28.40, DXR is doing good in the industry, outperforming 69.84% of the companies in the same industry.

DXR has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.

DXR's Debt to Equity ratio of 0.02 is fine compared to the rest of the industry. DXR outperforms 65.61% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.02
Debt/FCF	28.4
Altman-Z	27.92

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 0.02 indicates that DXR may have some problems paying its short term obligations.

DXR has a worse Current ratio (0.02) than 98.41% of its industry peers.

DXR has a Quick Ratio of 0.02. This is a bad value and indicates that DXR is not financially healthy enough and could expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 0.02, DXR is doing worse than 98.41% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	0.02
Quick Ratio	0.02

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 574.51% over the past year.

DXR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -54.84% yearly.

Looking at the last year, DXR shows a very negative growth in Revenue. The Revenue has decreased by -26.28% in the last year.

DXR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -20.63% yearly.

EPS 1Y (TTM)574.51%

EPS 3Y-54.84%

EPS 5YN/A

EPS Q2Q%-26.11%

Revenue 1Y (TTM)-26.28%

Revenue growth 3Y-24.67%

Revenue growth 5Y-20.63%

Sales Q2Q%-41.82%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 45.59 indicates a quite expensive valuation of DXR.

Compared to the rest of the industry, the Price/Earnings ratio of DXR indicates a somewhat cheap valuation: DXR is cheaper than 69.31% of the companies listed in the same industry.

The average S&P500 Price/Earnings ratio is at 24.21. DXR is valued rather expensively when compared to this.

		Industry Rank	Sector Rank
PE	45.59
Fwd PE	N/A

4.2 Price Multiples

DXR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DXR is cheaper than 67.20% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	1486.67
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for DXR!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DAXOR CORP

NASDAQ:DXR (5/9/2025, 8:00:01 PM)

7.75

+0.05 (+0.65%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)02-29 2024-02-29/amc

Earnings (Next)N/A N/A

Inst Owners2.3%

Inst Owner Change-0.48%

Ins Owners5.35%

Ins Owner Change1.49%

Market Cap38.21M

Analysts80

Price Target25.5 (229.03%)

Short Float %0.49%

Short Ratio1.45

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)6.38%

PT rev (3m)6.95%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	45.59
Fwd PE	N/A
P/S	318.93
P/FCF	1486.67
P/OCF	1486.67
P/B	1.07
P/tB	1.07
EV/EBITDA	N/A

EPS(TTM)0.17

EY2.19%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.01

FCFY0.07%

OCF(TTM)0.01

OCFY0.07%

SpS0.02

BVpS7.26

TBVpS7.26

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	1.46%
ROE	1.5%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	447.75%
GM	N/A
FCFM	21.45%

ROA(3y)6.45%

ROA(5y)5.61%

ROE(3y)6.73%

ROE(5y)6.34%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-35.84%

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0.02
Debt/FCF	28.4
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	4.79%
Current Ratio	0.02
Quick Ratio	0.02
Altman-Z	27.92

F-Score4

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)574.51%

EPS 3Y-54.84%

EPS 5YN/A

EPS Q2Q%-26.11%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-26.28%

Revenue growth 3Y-24.67%

Revenue growth 5Y-20.63%

Sales Q2Q%-41.82%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-75.24%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y100.7%

FCF growth 3YN/A

FCF growth 5Y-61.68%

OCF growth 1Y100.7%

OCF growth 3YN/A

OCF growth 5Y-61.68%

DAXOR CORP (DXR) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens